The Northeast Regional Center for Excellence in Vector-Borne Diseases, led by Cornell, has received a five-year, $8.7 million award from the Centers for Disease Control and Prevention to train and educate vector-borne disease professionals.
With a bit of funding, high school students not only helped their neighbors but also offered researchers insights into how young people think about their capacity to make a difference.
People who refused to get vaccinated against COVID-19 had low levels of social trust, weak attachments to the rule of law, and were less willing to honor collective commitments to the greater good, according to Cornell research published today.
An interdisciplinary research team received a five-year, $2 million grant from the National Science Foundation to develop a new generation of biosynthetic lubricants that have the potential to treat arthritis and reduce the painful friction of artificial joints.
Weill Cornell Medicine has been awarded a five-year, $11.6 million grant from the National Institute on Drug Abuse of the National Institutes of Health to study the effects cannabis, including marijuana and compounds derived from it, may have on the brains of those living with HIV.
Cornell researchers attached large fragments to temperamental "radical" molecules, increasing their girth to insulate them from their hyperreactive partners – a method that could help create improved derivatives of pharmaceutical compounds.
A member of an important class of ion channel proteins can transiently rearrange itself into a larger structure with dramatically altered properties, according to a study led by researchers at Weill Cornell Medicine.
Our 11th episode features Stephanie Wisner ’16, co-founder of Centivax, a therapeutics company that’s creating universal vaccines to reduce and eradicate the remaining complex pathogens of the 21st century.